XML 19 R5.htm IDEA: XBRL DOCUMENT v3.22.0.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Total revenue $ 31,944 $ 13,951 $ 12,602
Total cost of sales 46,092 24,952 16,655
Gross loss (14,148) (11,001) (4,053)
Operating expenses:      
Research and development 88,861 38,651 36,971
Sales and marketing 17,858 7,948 4,730
General and administrative 93,685 29,275 16,861
Total operating expenses 200,404 75,874 58,562
Loss from operations (214,552) (86,875) (62,615)
Change in fair value of SAFE notes 0 0 (24,215)
Change in fair value of warrant liabilities (26,126) (268,266) (256)
Loss on extinguishment of debt 0 (3,996) (6,124)
Interest expense and other (2,028) (2,885) (2,239)
Interest income and other 3,458 (276) 731
Total other income (expense), net (24,696) (275,423) (32,103)
Loss before income taxes (239,248) (362,298) (94,718)
Benefit from income taxes (1,262) 0 0
Net loss (237,986) (362,298) (94,718)
Net loss attributable to common stockholders $ (237,986) $ (369,055) $ (100,000)
Net loss per share attributable to common stockholders:      
Net loss per shares attributable to common shareholders- Basic (in dollars per share) $ (0.69) $ (2.54) $ (0.84)
Net loss per shares attributable to common shareholders- Diluted (in dollars per share) $ (0.69) $ (2.54) $ (0.84)
Shares used in computing net loss per share attributable to common stockholders:      
Basic (in shares) 346,300,975 145,096,996 118,835,912
Diluted (in shares) 346,300,975 145,096,996 118,835,912
Comprehensive Loss:      
Net loss $ (237,986) $ (362,298) $ (94,718)
Net unrealized gains (losses) on available-for-sale debt securities (942) 35 (1)
Comprehensive loss (238,928) (362,263) (94,719)
Products      
Total revenue 10,118 4,840 12,602
Total cost of sales 23,484 15,097 16,655
Services      
Total revenue 21,826 9,111 0
Total cost of sales $ 22,608 $ 9,855 $ 0